Gotham Asset Management’s 10x Genomics TXG Stock Holding History

Gotham Asset Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.44M	Buy	114,953 +20,236	+21%	+$405K	0.01%	1051
2025 Q4	$1.54M	Buy	94,717 +75,785	+400%	+$1.14M	0.01%	1123
2025 Q3	$221K	Sell	18,932 -57,606	-75%	-$751K	﹤0.01%	1593
2025 Q2	$886K	Buy	+76,538	New	+$698K	0.01%	1174
2025 Q1	–	Sell	-18,389	Closed	-$264K	–	1664
2024 Q4	$264K	Buy	+18,389	New	+$290K	﹤0.01%	1300
2024 Q1	–	Sell	-8,686	Closed	-$486K	–	1467
2023 Q4	$486K	Buy	8,686 +1,667	+24%	+$72.5K	0.01%	999
2023 Q3	$290K	Buy	7,019 +114	+2%	+$5.93K	0.01%	1129
2023 Q2	$386K	Buy	6,905 +1,881	+37%	+$102K	0.01%	1049
2023 Q1	$280K	Buy	+5,024	New	+$235K	0.01%	1153

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gotham Asset Management's TXG Position: Q1 2026 in Review

Gotham Asset Management increased its 10x Genomics (TXG) stake by 21% in Q1 2026, buying an estimated $405K and bringing the position to 114,953 shares worth $2.44M. The position accounts for 0.01% of the portfolio, ranked #1051.

Gotham Asset Management first reported a position in TXG in Q1 2023 and has held it in 9 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Gotham Asset Management held 114,953 shares of 10x Genomics worth $2.44M as of Q1 2026.
Gotham Asset Management bought 20,236 10x Genomics shares in Q1 2026, an estimated $405K.
10x Genomics made up 0.01% of Gotham Asset Management's portfolio in Q1 2026, its #1051 holding.
Gotham Asset Management first reported a position in 10x Genomics in Q1 2023 and has held it in 9 quarters since.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.